Market Pulse Archives

Dec. 8, 2021, 9:40 a.m. EST

Dow, S& P 500 fight to bring string of gains to three as investors assess vaccine efficacy against omicron

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Pfizer Inc. (PFE)
  • X
    BioNTech SE ADR (BNTX)
  • X
    Dow Jones Industrial Average (DJIA)

or Cancel Already have a watchlist? Log In

By Mark Decambre

U.S. stock benchmarks traded mixed early Wednesday as investors weighed the efficacy of vaccines and treatments against the omicron variant of coronavirus that causes COVID-19. Pfizer /zigman2/quotes/202877789/composite PFE +2.19% and BioNTech /zigman2/quotes/214419716/composite BNTX +3.77% said Wednesday that a third dose of their CCOVID-19 vaccine neutralized the new strain in lab tests, but that a two-dose regimen was much less effective. The Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.34% was up less than 0.1% at 35,737, and the S&P 500 index /zigman2/quotes/210599714/realtime SPX +1.01% was trading less than 0.1% lower at 4,687. The Nasdaq Composite Index /zigman2/quotes/210598365/realtime COMP +1.63% was down 0.3% at 15,637.

/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 54.54
+1.17 +2.19%
Volume: 11.73M
Jan. 28, 2022 12:32p
P/E Ratio
16.18
Dividend Yield
2.94%
Market Cap
$299.56 billion
Rev. per Employee
$883,274
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 160.37
+5.83 +3.77%
Volume: 908,726
Jan. 28, 2022 12:32p
P/E Ratio
4.62
Dividend Yield
N/A
Market Cap
$37.48 billion
Rev. per Employee
$8.48M
loading...
/zigman2/quotes/210598065/realtime
US : Dow Jones Global
34,276.15
+115.37 +0.34%
Volume: 283.43M
Jan. 28, 2022 12:32p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,370.28
+43.77 +1.01%
Volume: 1.34B
Jan. 28, 2022 12:32p
loading...
/zigman2/quotes/210598365/realtime
US : Nasdaq
13,571.07
+218.29 +1.63%
Volume: 2.21M
Jan. 28, 2022 12:32p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.